BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zou W, Devi SS, Sparkenbaugh E, Younis HS, Roth RA, Ganey PE. Hepatotoxic interaction of sulindac with lipopolysaccharide: role of the hemostatic system. Toxicol Sci 2009;108:184-93. [PMID: 19074762 DOI: 10.1093/toxsci/kfn259] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Giustarini G, Kruijssen L, van Roest M, Bleumink R, Weaver RJ, Bol-schoenmakers M, Smit J, Pieters R. Tissue influx of neutrophils and monocytes is delayed during development of trovafloxacin-induced tumor necrosis factor-dependent liver injury in mice: Delayed influx of innate immune cells in drug-induced liver injury. J Appl Toxicol 2018;38:753-65. [DOI: 10.1002/jat.3585] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
2 Giri S, Nieber K, Bader A. Hepatotoxicity and hepatic metabolism of available drugs: current problems and possible solutions in preclinical stages. Expert Opinion on Drug Metabolism & Toxicology 2010;6:895-917. [DOI: 10.1517/17425251003792521] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
3 Zou W, Roth RA, Younis HS, Malle E, Ganey PE. Neutrophil-cytokine interactions in a rat model of sulindac-induced idiosyncratic liver injury. Toxicology 2011;290:278-85. [PMID: 22019926 DOI: 10.1016/j.tox.2011.10.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
4 Giri S, Bader A. Improved preclinical safety assessment using micro-BAL devices: the potential impact on human discovery and drug attrition. Drug Discov Today 2011;16:382-97. [PMID: 21354326 DOI: 10.1016/j.drudis.2011.02.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
5 Rao T, Liu YT, Zeng XC, Li CP, Ou-Yang DS. The hepatotoxicity of Polygonum multiflorum: The emerging role of the immune-mediated liver injury. Acta Pharmacol Sin. 2021;42:27-35. [PMID: 32123300 DOI: 10.1038/s41401-020-0360-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
6 Sparkenbaugh EM, Ganey PE, Roth RA. Hypoxia sensitization of hepatocytes to neutrophil elastase-mediated cell death depends on MAPKs and HIF-1α. Am J Physiol Gastrointest Liver Physiol 2012;302:G748-57. [PMID: 22223132 DOI: 10.1152/ajpgi.00409.2011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
7 Corsini A, Ganey P, Ju C, Kaplowitz N, Pessayre D, Roth R, Watkins PB, Albassam M, Liu B, Stancic S, Suter L, Bortolini M. Current Challenges and Controversies in Drug-Induced Liver Injury. Drug Saf 2012;35:1099-117. [DOI: 10.1007/bf03261997] [Cited by in Crossref: 44] [Cited by in F6Publishing: 14] [Article Influence: 4.4] [Reference Citation Analysis]
8 Zuurmond A, Koudijs A, van El B, Doornbos RP, van Manen-vernooij BC, Bastiaans JH, Penninks AH, van Bilsen JH, Cnubben NH, Degroot J. Integration of efficacy, pharmacokinetic and safety assessment of interleukin-1 receptor antagonist in a preclinical model of arthritis. Regulatory Toxicology and Pharmacology 2011;59:461-70. [DOI: 10.1016/j.yrtph.2011.01.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
9 Higuchi S, Kobayashi M, Yoshikawa Y, Tsuneyama K, Fukami T, Nakajima M, Yokoi T. IL-4 mediates dicloxacillin-induced liver injury in mice. Toxicol Lett. 2011;200:139-145. [PMID: 21094227 DOI: 10.1016/j.toxlet.2010.11.006] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
10 Corsini A, Ganey P, Ju C, Kaplowitz N, Pessayre D, Roth R, Watkins PB, Albassam M, Liu B, Stancic S. Current challenges and controversies in drug-induced liver injury. Drug Saf. 2012;35:1099-1117. [PMID: 23137150 DOI: 10.2165/11632970-000000000-00000] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Shaw PJ, Ganey PE, Roth RA. Idiosyncratic drug-induced liver injury and the role of inflammatory stress with an emphasis on an animal model of trovafloxacin hepatotoxicity. Toxicol Sci 2010;118:7-18. [PMID: 20538741 DOI: 10.1093/toxsci/kfq168] [Cited by in Crossref: 84] [Cited by in F6Publishing: 67] [Article Influence: 7.0] [Reference Citation Analysis]
12 Bessone F. Non-steroidal anti-inflammatory drugs: What is the actual risk of liver damage? World J Gastroenterol 2010; 16(45): 5651-5661 [PMID: 21128314 DOI: 10.3748/wjg.v16.i45.5651] [Cited by in CrossRef: 141] [Cited by in F6Publishing: 114] [Article Influence: 11.8] [Reference Citation Analysis]
13 Iida A, Sasaki E, Yano A, Tsuneyama K, Fukami T, Nakajima M, Yokoi T. Carbamazepine-Induced Liver Injury Requires CYP3A-Mediated Metabolism and Glutathione Depletion in Rats. Drug Metab Dispos 2015;43:958-68. [DOI: 10.1124/dmd.115.063370] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
14 Cullen JM, Faiola B, Melich DH, Peterson RA, Jordan HL, Kimbrough CL, Miller RT. Acute Alpha-Naphthylisothiocyanate-induced Liver Toxicity in Germfree and Conventional Male Rats. Toxicol Pathol 2016;44:987-97. [PMID: 27519817 DOI: 10.1177/0192623316662360] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
15 Segovia-zafra A, Di Zeo-sánchez DE, López-gómez C, Pérez-valdés Z, García-fuentes E, Andrade RJ, Lucena MI, Villanueva-paz M. Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction. Acta Pharmaceutica Sinica B 2021;11:3685-726. [DOI: 10.1016/j.apsb.2021.11.013] [Reference Citation Analysis]
16 Roth RA, Ganey PE. Animal models of idiosyncratic drug-induced liver injury—Current status. Critical Reviews in Toxicology 2011;41:723-39. [DOI: 10.3109/10408444.2011.575765] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 4.6] [Reference Citation Analysis]
17 Roth RA, Ganey PE. Intrinsic versus idiosyncratic drug-induced hepatotoxicity--two villains or one? J Pharmacol Exp Ther. 2010;332:692-697. [PMID: 20019161 DOI: 10.1124/jpet.109.162651] [Cited by in Crossref: 99] [Cited by in F6Publishing: 78] [Article Influence: 7.6] [Reference Citation Analysis]
18 Deng X, Luyendyk JP, Ganey PE, Roth RA. Inflammatory stress and idiosyncratic hepatotoxicity: hints from animal models. Pharmacol Rev 2009;61:262-82. [PMID: 19805476 DOI: 10.1124/pr.109.001727] [Cited by in Crossref: 94] [Cited by in F6Publishing: 80] [Article Influence: 7.8] [Reference Citation Analysis]
19 Lu J, Roth RA, Malle E, Ganey PE. Roles of the hemostatic system and neutrophils in liver injury from co-exposure to amiodarone and lipopolysaccharide. Toxicol Sci 2013;136:51-62. [PMID: 23912913 DOI: 10.1093/toxsci/kft170] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
20 Giustarini G, Huppelschoten S, Barra M, Oppelt A, Wagenaar L, Weaver RJ, Bol-Schoenmakers M, Smit JJ, van de Water B, Klingmüller U, Pieters RHH. The hepatotoxic fluoroquinolone trovafloxacin disturbs TNF- and LPS-induced p65 nuclear translocation in vivo and in vitro. Toxicol Appl Pharmacol 2020;391:114915. [PMID: 32035082 DOI: 10.1016/j.taap.2020.114915] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Su Y, Zhang Y, Chen M, Jiang Z, Sun L, Wang T, Zhang L. Lipopolysaccharide exposure augments isoniazide-induced liver injury. J Appl Toxicol 2014;34:1436-42. [PMID: 25331106 DOI: 10.1002/jat.2979] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
22 Zou W, Beggs KM, Sparkenbaugh EM, Jones AD, Younis HS, Roth RA, Ganey PE. Sulindac metabolism and synergy with tumor necrosis factor-alpha in a drug-inflammation interaction model of idiosyncratic liver injury. J Pharmacol Exp Ther 2009;331:114-21. [PMID: 19638570 DOI: 10.1124/jpet.109.156331] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
23 Padberg F, Höper T, Henkel S, Driesch D, Luch A, Zellmer S. Novel indirect co-culture of immortalised hepatocytes with monocyte derived macrophages is characterised by pro-inflammatory cytokine networks. Toxicol In Vitro 2021;73:105134. [PMID: 33662514 DOI: 10.1016/j.tiv.2021.105134] [Reference Citation Analysis]
24 Zou W, Roth RA, Younis HS, Burgoon LD, Ganey PE. Oxidative stress is important in the pathogenesis of liver injury induced by sulindac and lipopolysaccharide cotreatment. Toxicology 2010;272:32-8. [PMID: 20371263 DOI: 10.1016/j.tox.2010.03.015] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
25 Kobayashi M, Higuchi S, Ide M, Nishikawa S, Fukami T, Nakajima M, Yokoi T. Th2 cytokine-mediated methimazole-induced acute liver injury in mice: Methimazole-induced hepatotoxicity. J Appl Toxicol 2012;32:823-33. [DOI: 10.1002/jat.2731] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
26 Minagawa K, Berber MR, Hafez IH, Mori T, Tanaka M. Target delivery and controlled release of the chemopreventive drug sulindac by using an advanced layered double hydroxide nanomatrix formulation system. J Mater Sci Mater Med 2012;23:973-81. [PMID: 22350776 DOI: 10.1007/s10856-012-4566-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
27 Ramm S, Morissey B, Hernandez B, Rooney C, Pennington SR, Mally A. Application of a discovery to targeted LC-MS proteomics approach to identify deregulated proteins associated with idiosyncratic liver toxicity in a rat model of LPS/diclofenac co-administration. Toxicology 2015;331:100-11. [PMID: 25772430 DOI: 10.1016/j.tox.2015.03.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
28 Ramm S, Mally A. Role of drug-independent stress factors in liver injury associated with diclofenac intake. Toxicology 2013;312:83-96. [PMID: 23939143 DOI: 10.1016/j.tox.2013.08.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
29 Lu J, Miyakawa K, Roth RA, Ganey PE. Tumor necrosis factor-alpha potentiates the cytotoxicity of amiodarone in Hepa1c1c7 cells: roles of caspase activation and oxidative stress. Toxicol Sci 2013;131:164-78. [PMID: 23042730 DOI: 10.1093/toxsci/kfs289] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
30 Lu J, Jones AD, Harkema JR, Roth RA, Ganey PE. Amiodarone exposure during modest inflammation induces idiosyncrasy-like liver injury in rats: role of tumor necrosis factor-alpha. Toxicol Sci. 2012;125:126-133. [PMID: 21984482 DOI: 10.1093/toxsci/kfr266] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
31 Wu W, Wang T, Sun B, Liu D, Lin Z, Miao Y, Wang C, Geng X, Li B. Xian-Ling-Gu-Bao induced inflammatory stress rat liver injury: Inflammatory and oxidative stress playing important roles. Journal of Ethnopharmacology 2019;239:111910. [DOI: 10.1016/j.jep.2019.111910] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
32 Roth RA, Ganey PE. Role of Inflammation in Drug-Induced Liver Injury. Drug-Induced Liver Disease. Elsevier; 2013. pp. 157-73. [DOI: 10.1016/b978-0-12-387817-5.00010-8] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
33 Beggs KM, Fullerton AM, Miyakawa K, Ganey PE, Roth RA. Molecular mechanisms of hepatocellular apoptosis induced by trovafloxacin-tumor necrosis factor-alpha interaction. Toxicol Sci 2014;137:91-101. [PMID: 24097668 DOI: 10.1093/toxsci/kft226] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
34 Luyendyk J, Roth R, Ganey P. Inflammation and Hepatotoxicity. Comprehensive Toxicology. Elsevier; 2010. pp. 295-317. [DOI: 10.1016/b978-0-08-046884-6.01031-9] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
35 Hastings KL, Green MD, Gao B, Ganey PE, Roth RA, Burleson GR. Beyond Metabolism: Role of the Immune System in Hepatic Toxicity. Int J Toxicol 2020;39:151-64. [PMID: 32174281 DOI: 10.1177/1091581819898399] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Shaw PJ, Beggs KM, Sparkenbaugh EM, Dugan CM, Ganey PE, Roth RA. Trovafloxacin enhances TNF-induced inflammatory stress and cell death signaling and reduces TNF clearance in a murine model of idiosyncratic hepatotoxicity. Toxicol Sci 2009;111:288-301. [PMID: 19638433 DOI: 10.1093/toxsci/kfp163] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
37 Hadi M, Westra IM, Starokozhko V, Dragovic S, Merema MT, Groothuis GM. Human precision-cut liver slices as an ex vivo model to study idiosyncratic drug-induced liver injury. Chem Res Toxicol. 2013;26:710-720. [PMID: 23565644 DOI: 10.1021/tx300519p] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
38 Pan Y, Cao M, You D, Qin G, Liu Z. Research Progress on the Animal Models of Drug-Induced Liver Injury: Current Status and Further Perspectives. Biomed Res Int 2019;2019:1283824. [PMID: 31119149 DOI: 10.1155/2019/1283824] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]